Clinical trial
A Randomized Phase II Multicenter Controlled Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
NCT00591045 is registered in ClinicalTrials.gov with Peking University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Multicenter Controlled Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
- Lead sponsor
- Peking University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2008
- Completion date
- December 31, 2012
- Enrollment
- 263 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer, stomach neoplasms